A comprehensive measure set comprising 10 performance measures and 3 quality measures was developed to advance evidence-based care for patients with chronic coronary disease.
The AHA/ACC developed a new set of 10 performance and 3 quality measures to optimize evidence-based care for patients with chronic coronary disease.
Chronic coronary disease (CCD) is the leading cause of death in the United States. There is an ongoing imperative to disseminate evidence-based and patient-centered care recommendations that further align the management of patients with CCD to updated evidence-based guidelines. The writing committee developed a comprehensive CCD measure set comprising 10 performance measures and 3 quality measures, the focus of which is to include practical steps to specifically advance care in the CCD population. The measure set begins with an assessment of tobacco use and evidence-based cessation interventions. Also included are topics such as antiplatelet therapy, lipid assessment and low-density lipoprotein cholesterol goals, and guideline-directed management and therapy for hypertension and reduced left ventricular dysfunction in patients with CCD. The measure set concludes with an emphasis on the importance of cardiac rehabilitation referral and patient education, including symptom management and lifestyle modification.
“For patients with chronic coronary disease, the landscape is changing as we advance care. The document is meant to help spread the word and really allow [clinicians] to know how we should we be managing our patients now. It can be intimidating to say, well, this changes and that changes and this changes” without knowing what to prioritize amid all the various sources of information.”
Williams et al. (2025) studied Chronic coronary disease. Clinical Performance and Quality Measures was evaluated. A comprehensive measure set comprising 10 performance measures and 3 quality measures was developed to advance evidence-based care for patients with chronic coronary disease.